Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests $101
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests $229
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  2. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  3. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  4. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  5. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  6. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  7. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  8. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  9. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  10. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  11. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  12. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  13. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  14. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  15. Mair F, et al. 2022. Nature. 605:728. PubMed
  16. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  17. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  18. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  19. Campisi L, et al. 2022. Nature. 606:945. PubMed
  20. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  21. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  22. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  23. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  24. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  25. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  26. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  27. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  28. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  29. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  30. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  31. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  32. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  33. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  34. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  35. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  36. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  37. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  38. Sun W, et al. 2023. Nature. 614:309. PubMed
  39. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  40. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  41. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  42. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  43. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  44. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  45. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  46. Wang CQ, et al. 2023. Cells. 12: . PubMed
  47. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  48. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  49. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  50. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  51. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  52. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  53. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  54. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  55. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  56. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  57. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  58. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  59. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  60. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  61. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  62. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  63. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  64. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  65. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  66. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  67. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  68. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  69. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  70. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  71. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  72. Li S, et al. 2022. Nature. 610:373. PubMed
  73. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  74. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  75. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  76. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  77. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  78. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  79. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  80. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  81. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  82. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  83. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  84. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  85. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  86. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  87. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  88. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  89. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  90. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  91. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  92. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  93. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  94. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  95. Gao F, et al. 2023. Immunity. 56:864. PubMed
  96. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  97. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  98. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  99. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  100. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  101. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  102. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  103. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  104. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  105. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  106. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  107. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  108. Solier S, et al. 2023. Nature. 617:386. PubMed
  109. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  110. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  111. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  112. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  113. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  114. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  115. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  116. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  117. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  118. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  119. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  120. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  121. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  122. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  123. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  124. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  125. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  126. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  127. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  128. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  129. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  130. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  131. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  132. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  133. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  134. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  135. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  136. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  137. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  138. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  139. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  140. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  141. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  142. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  143. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  144. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  145. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  146. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  147. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  148. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  149. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  150. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  151. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  152. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  153. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  154. Jairaman A, et al. 2022. Elife. 11:. PubMed
  155. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  156. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  157. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  158. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  159. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  160. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  161. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  162. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  163. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  164. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  165. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  166. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  167. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  168. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  169. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  170. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  171. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  172. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  173. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  174. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  175. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  176. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  177. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  178. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  179. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  180. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  181. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  182. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  183. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  184. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  185. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  186. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  187. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  188. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  189. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  190. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  191. Ogbe A, et al. 2022. JCI Insight. . PubMed
  192. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  193. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  194. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  195. Woodruff MC, et al. 2022. Nature. :. PubMed
  196. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  197. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  198. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  199. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  200. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  201. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  202. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  203. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  204. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  205. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  206. Kumar V, et al. 2022. Cells. 11:. PubMed
  207. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  208. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  209. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  210. Vijayakumar B, et al. 2022. Immunity. . PubMed
  211. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  212. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  213. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  214. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  215. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  216. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  217. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  218. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  219. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  220. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  221. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  222. Dogra P, et al. 2020. Cell. 749:180. PubMed
  223. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  224. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  225. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  226. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  227. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  228. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  229. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  230. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  231. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  232. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  233. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  234. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  235. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  236. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  237. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  238. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  239. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  240. Kreutmair S, et al. 2021. Immunity. . PubMed
  241. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  242. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  243. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  244. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  245. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  246. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  247. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  248. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  249. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  250. Romine KA, et al. 2021. Cancer Discov. . PubMed
  251. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  252. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  253. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  254. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  255. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  256. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  257. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  258. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  259. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  260. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  261. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  262. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  263. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  264. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  265. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  266. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  267. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  268. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  269. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  270. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  271. Thijssen R, et al. 2022. Blood. :. PubMed
  272. Good Z, et al. 2022. Nat Med. :. PubMed
  273. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  274. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  275. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  276. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  277. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  278. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  279. Shi J, et al. 2014. Blood. 123:4015. PubMed
  280. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  281. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  282. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  283. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  284. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  285. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  286. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  287. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  288. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  289. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  290. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  291. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  292. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  293. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  294. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  295. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  296. Woodruff M, et al. 2020. medRxiv. . PubMed
  297. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  298. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  299. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  300. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  301. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  302. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  303. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  304. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  305. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  306. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  307. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  308. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  309. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  310. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  311. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  312. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  313. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  314. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  315. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  316. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  317. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  318. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  319. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  320. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  321. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  322. Burns JC, et al. 2020. eLife. 9:00. PubMed
  323. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  324. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  325. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  326. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  327. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  328. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  329. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  330. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  331. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  332. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  333. Wang J, et al. 2022. iScience. 25:103971. PubMed
  334. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  335. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  336. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  337. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  338. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  339. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  340. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  341. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  342. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  343. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  344. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  345. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  346. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  347. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  348. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  349. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  350. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  351. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  352. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  353. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  354. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  355. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  356. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  357. Song M, et al. 2018. Nature. 562:423. PubMed
  358. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  359. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  360. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  361. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  362. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  363. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  364. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  365. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  366. Feng W, et al. 2020. J Vis Exp. . PubMed
  367. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  368. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  369. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  370. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  371. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  372. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  373. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  374. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  375. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  376. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  377. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  378. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  379. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  380. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  381. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  382. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  383. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  384. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  385. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  386. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  387. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  388. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  389. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  390. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  391. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  392. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  393. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  394. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  395. Georg P, et al. 2022. Cell. 185:493. PubMed
  396. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  397. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  398. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  399. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  400. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  401. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  402. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  403. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  404. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  405. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  406. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  407. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  408. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  409. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  410. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  411. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  412. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  413. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  414. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  415. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  416. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  417. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  418. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  419. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  420. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  421. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  422. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  423. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  424. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  425. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  426. Lederer K, et al. 2022. Cell. . PubMed
  427. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  428. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  429. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  430. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  431. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  432. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  433. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  434. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  435. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  436. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  437. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  438. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  439. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  440. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  441. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  442. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  443. Adamo S, et al. 2022. Nature. 602:148. PubMed
  444. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  445. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  446. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  447. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  448. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  449. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  450. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  451. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  452. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  453. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  454. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  455. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  456. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  457. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  458. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  459. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  460. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  461. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  462. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  463. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  464. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  465. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  466. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  467. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  468. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  469. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  470. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  471. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  472. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  473. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  474. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  475. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  476. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  477. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  478. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  479. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  480. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  481. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  482. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  483. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  484. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  485. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  486. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  487. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  488. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  489. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  490. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  491. Chen C, et al. 2022. iScience. 25:103645. PubMed
  492. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  493. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  494. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  495. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  496. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  497. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  498. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  499. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  500. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  501. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  502. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  503. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  504. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  505. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  506. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  507. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  508. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  509. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  510. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  511. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  512. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  513. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  514. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  515. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  516. Wang EY, et al. 2021. Nature. 595:283. PubMed
  517. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  518. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  519. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  520. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  521. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  522. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  523. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  524. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  525. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  526. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  527. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  528. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  529. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account